Sanofi SA's (NASDAQ:SNY) newly minted CEO is looking under the hood to figure out what's needed to get the company in gear. Shareholders are hoping he's successful. The French pharmaceutical giant has been stuck in neutral for a while, with its shares off a few dollars from where they were two years ago.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,